Cargando…

Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease

BACKGROUND: Associations between cardiovascular diseases and mercury have been frequently described, but underlying mechanisms are poorly understood. OBJECTIVES: We investigate the procoagulant activation of erythrocytes, an important contributor to thrombosis, by low-level mercury to explore the ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Kyung-Min, Kim, Sujin, Noh, Ji-Yoon, Kim, Keunyoung, Jang, Won-Hee, Bae, Ok-Nam, Chung, Seung-Min, Chung, Jin-Ho
Formato: Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920911/
https://www.ncbi.nlm.nih.gov/pubmed/20308036
http://dx.doi.org/10.1289/ehp.0901473
_version_ 1782185331303383040
author Lim, Kyung-Min
Kim, Sujin
Noh, Ji-Yoon
Kim, Keunyoung
Jang, Won-Hee
Bae, Ok-Nam
Chung, Seung-Min
Chung, Jin-Ho
author_facet Lim, Kyung-Min
Kim, Sujin
Noh, Ji-Yoon
Kim, Keunyoung
Jang, Won-Hee
Bae, Ok-Nam
Chung, Seung-Min
Chung, Jin-Ho
author_sort Lim, Kyung-Min
collection PubMed
description BACKGROUND: Associations between cardiovascular diseases and mercury have been frequently described, but underlying mechanisms are poorly understood. OBJECTIVES: We investigate the procoagulant activation of erythrocytes, an important contributor to thrombosis, by low-level mercury to explore the roles of erythrocytes in mercury-related cardiovascular diseases. METHODS: We used freshly isolated human erythrocytes and ex vivo and in vivo thrombosis models in rats to investigate mercury-induced procoagulant activity. RESULTS: Prolonged exposure to low-dose mercuric ion (Hg(2+); 0.25–5 μM for 1–48 hr) induced erythrocyte shape changes from discocytes to echinocytes to spherocytes, accompanied by microvesicle (MV) generation. These MVs and remnant erythrocytes expressed phosphatidylserine (PS), an important mediator of procoagulant activation. Hg(2+) inhibited flippase, an enzyme that recovers PS into the inner leaflet of the cell membrane, and activated scramblase, an enzyme that alters lipid asymmetry in the cell membrane. Consistent with these activity changes, Hg(2+) increased intracellular calcium and depleted ATP and protein thiol. A thiol supplement reversed Hg(2+)-induced MV generation and PS exposure and inhibited the increase in calcium ion (Ca(2+)) and depletion of ATP, indicating that free-thiol depletion was critical to Hg(2+)-mediated procoagulant activity. The procoagulant activity of Hg(2+)-treated erythrocytes was demonstrated by increased thrombin generation and endothelial cell adhesion. We further confirmed Hg(2+)-mediated procoagulant activation of erythrocytes in ex vivo and in vivo rat thrombosis models, where Hg(2+) treatment (0.5–2.5 mg/kg) increased PS exposure and thrombus formation significantly. CONCLUSION: This study demonstrated that mercury could provoke procoagulant activity in erythrocytes through protein-thiol depletion–mediated PS exposure and MV generation, ultimately leading to enhanced thrombosis.
format Text
id pubmed-2920911
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-29209112010-08-13 Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease Lim, Kyung-Min Kim, Sujin Noh, Ji-Yoon Kim, Keunyoung Jang, Won-Hee Bae, Ok-Nam Chung, Seung-Min Chung, Jin-Ho Environ Health Perspect Research BACKGROUND: Associations between cardiovascular diseases and mercury have been frequently described, but underlying mechanisms are poorly understood. OBJECTIVES: We investigate the procoagulant activation of erythrocytes, an important contributor to thrombosis, by low-level mercury to explore the roles of erythrocytes in mercury-related cardiovascular diseases. METHODS: We used freshly isolated human erythrocytes and ex vivo and in vivo thrombosis models in rats to investigate mercury-induced procoagulant activity. RESULTS: Prolonged exposure to low-dose mercuric ion (Hg(2+); 0.25–5 μM for 1–48 hr) induced erythrocyte shape changes from discocytes to echinocytes to spherocytes, accompanied by microvesicle (MV) generation. These MVs and remnant erythrocytes expressed phosphatidylserine (PS), an important mediator of procoagulant activation. Hg(2+) inhibited flippase, an enzyme that recovers PS into the inner leaflet of the cell membrane, and activated scramblase, an enzyme that alters lipid asymmetry in the cell membrane. Consistent with these activity changes, Hg(2+) increased intracellular calcium and depleted ATP and protein thiol. A thiol supplement reversed Hg(2+)-induced MV generation and PS exposure and inhibited the increase in calcium ion (Ca(2+)) and depletion of ATP, indicating that free-thiol depletion was critical to Hg(2+)-mediated procoagulant activity. The procoagulant activity of Hg(2+)-treated erythrocytes was demonstrated by increased thrombin generation and endothelial cell adhesion. We further confirmed Hg(2+)-mediated procoagulant activation of erythrocytes in ex vivo and in vivo rat thrombosis models, where Hg(2+) treatment (0.5–2.5 mg/kg) increased PS exposure and thrombus formation significantly. CONCLUSION: This study demonstrated that mercury could provoke procoagulant activity in erythrocytes through protein-thiol depletion–mediated PS exposure and MV generation, ultimately leading to enhanced thrombosis. National Institute of Environmental Health Sciences 2010-07 2010-03-23 /pmc/articles/PMC2920911/ /pubmed/20308036 http://dx.doi.org/10.1289/ehp.0901473 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Lim, Kyung-Min
Kim, Sujin
Noh, Ji-Yoon
Kim, Keunyoung
Jang, Won-Hee
Bae, Ok-Nam
Chung, Seung-Min
Chung, Jin-Ho
Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease
title Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease
title_full Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease
title_fullStr Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease
title_full_unstemmed Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease
title_short Low-Level Mercury Can Enhance Procoagulant Activity of Erythrocytes: A New Contributing Factor for Mercury-Related Thrombotic Disease
title_sort low-level mercury can enhance procoagulant activity of erythrocytes: a new contributing factor for mercury-related thrombotic disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920911/
https://www.ncbi.nlm.nih.gov/pubmed/20308036
http://dx.doi.org/10.1289/ehp.0901473
work_keys_str_mv AT limkyungmin lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease
AT kimsujin lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease
AT nohjiyoon lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease
AT kimkeunyoung lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease
AT jangwonhee lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease
AT baeoknam lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease
AT chungseungmin lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease
AT chungjinho lowlevelmercurycanenhanceprocoagulantactivityoferythrocytesanewcontributingfactorformercuryrelatedthromboticdisease